Byline: Ben Schamisso
-
Novel AI Tool Rapidly Measures Colonoscopy Quality
Northwestern scientists have developed an AI tool that rapidly and successfully measures colonoscopy quality by reviewing footage of the procedure.
-
RNA Therapy May Help Preserve Muscle During GLP-1 Weight Loss
A new Northwestern University study offers a potential solution to muscle loss during GLP-1 therapy: an experimental RNA therapy that induces the body to burn calories, enhancing the benefits of the weight-loss treatment.
-
Assessing the Benefit of Heart Calcium Scans
A new Northwestern Medicine study shows that a test known as a coronary artery calcium scan may be most valuable only for a specific group of patients.
-
Loneliness Rewires the Brain to Drive Alcohol Consumption, Mouse Study Finds
Loneliness can reprogram the brain in ways that push alcohol consumption, reports a new preclinical study led by Northwestern University and the Salk Institute for Biological Studies.
-
Blood Test Spots Hidden Pancreatic Cancer After Treatment
A highly sensitive blood test can detect traces of pancreatic cancer missed by standard testing, potentially helping physicians identify patients whose disease is more likely to return even when scans appear reassuring.
-
Asthma Drug Improves Treatment of Aggressive Cancers in Preclinical Studies
A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine study that uncovered how tumors hijack common white blood cells to evade immunotherapy.
-
Little-Used Cholesterol Test Could Prevent More Heart Attacks, Strokes
A new Northwestern Medicine study published in JAMA has found that a little-used cholesterol test outperformed standard tests in guiding cholesterol-lowering therapy.
-
New Drug Doubles One-Year Survival in Pancreatic Cancer Trial
Patients who received an experimental drug developed at Northwestern University alongside standard chemotherapy were twice as likely to be alive after one year of treatment, compared to those receiving chemotherapy alone.
-
Premature Menopause Raises Long-Term Heart Risk by 40 Percent
Women who enter natural menopause before age 40 face about a 40 percent higher lifetime risk of developing coronary heart disease than women who experience menopause later, according to a large Northwestern Medicine study.
-
Long COVID Brain Fog Far More Common in US than India, Other Nations
Patients with long COVID-19 in the U.S. report far higher rates of brain fog, depression and cognitive symptoms than patients in countries such as India and Nigeria, according to a large international study led by Northwestern Medicine.
